Literature DB >> 26456254

Clinical and Molecular Inflammatory Response in Sjögren Syndrome-Associated Dry Eye Patients Under Desiccating Stress.

Alberto López-Miguel1, Marisa Tesón2, Vicente Martín-Montañez2, Amalia Enríquez-de-Salamanca3, Michael E Stern4, María J González-García3, Margarita Calonge5.   

Abstract

PURPOSE: To evaluate the response of the lacrimal function unit in Sjögren syndrome (SS)-associated dry eye patients exposed to 2 simulated daily life environmental conditions.
DESIGN: Prospective crossover pilot study.
METHODS: Fourteen female SS dry eye patients were exposed for 2 hours to a controlled normal condition (23 C, 45% relative humidity, and air flow 0.10 m/s) and a controlled adverse condition that simulates desiccating stress (23 C, 5% relative humidity, and air flow 0.10 m/s). The following dry eye tests were performed before and after the exposure: tear osmolarity, phenol red thread test, conjunctival hyperemia, fluorescein tear break-up time, corneal fluorescein staining, conjunctival lissamine green staining, and Schirmer test. Levels of 16 molecules were analyzed in tears by multiplex immunobead analysis.
RESULTS: Clinical evaluation showed lacrimal functional unit impairment after the desiccating stress: significantly increased tear osmolarity (315.7 ± 3.0 vs 327.7 ± 5.1 mOsm/L, P = .03), conjunctival hyperemia (1.3 ± 0.1 vs 1.6 ± 0.1, P = .05), and corneal staining in temporal (3.5 ± 0.5 vs 4.7 ± 0.4, P = .01) and nasal (3.6 ± 0.5 vs 4.5 ± 0.5, P = .04) areas. Tear concentrations increased for interleukin-1 receptor antagonist (16 557.1 ± 4047.8 vs 31 895.3 ± 5916.5 pg/mL, P = .01), interleukin-6 (63.8 ± 20.2 vs 111.5 ± 29.6 pg/mL, P = .02), interleukin-8 (2196.1 ± 737.9 vs 3753.2 ± 1106.0 pg/mL, P = .03), and matrix metalloproteinase-9 (101 515.6 ± 37 088.4 vs 145 867.1 ± 41 651.5 pg/mL, P = .03). After the simulated normal condition, only a significant increase in nasal corneal staining (2.9 ± 0.5 vs 3.6 ± 0.5, P = .03) was observed.
CONCLUSIONS: Even a short exposure to a desiccating environment can produce a significant deterioration of the lacrimal function unit in female SS dry eye patients. The often unnoticed exposure to these conditions during daily life may increase inflammatory activity rapidly, triggering an ocular surface deterioration.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26456254     DOI: 10.1016/j.ajo.2015.09.039

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

Review 1.  The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.

Authors:  Claudia Fabiani; Jurgen Sota; Gian Marco Tosi; Rossella Franceschini; Bruno Frediani; Mauro Galeazzi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-12-28       Impact factor: 2.980

2.  Impact of Low Humidity on Damage-associated Molecular Patterns at the Ocular Surface during Dry Eye Disease.

Authors:  Alyce Alven; Carolina Lema; Rachel L Redfern
Journal:  Optom Vis Sci       Date:  2021-11-01       Impact factor: 1.973

Review 3.  Therapeutic Potential of Microvesicles in Cell Therapy and Regenerative Medicine of Ocular Diseases With an Especial Focus on Mesenchymal Stem Cells-Derived Microvesicles.

Authors:  Lina Moallemi Rad; Alexey V Yumashev; Bashdar Mahmud Hussen; Hazha Hadayat Jamad; Soudeh Ghafouri-Fard; Mohammad Taheri; Samaneh Rostami; Vahid Niazi; Mohammadreza Hajiesmaeili
Journal:  Front Genet       Date:  2022-03-29       Impact factor: 4.599

Review 4.  Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.

Authors:  Suzanne Hagan; Eilidh Martin; Amalia Enríquez-de-Salamanca
Journal:  EPMA J       Date:  2016-07-13       Impact factor: 6.543

5.  Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation.

Authors:  Javier Soria; Arantxa Acera; Jesús Merayo-LLoves; Juan A Durán; Nerea González; Sandra Rodriguez; Nikitas Bistolas; Soeren Schumacher; Frank F Bier; Harald Peter; Walter Stöcklein; Tatiana Suárez
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

6.  Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren's syndrome.

Authors:  Lara A Aqrawi; Xiangjun Chen; Janicke Liaaen Jensen; Mathias Kaurstad Morthen; Bernd Thiede; Øygunn Aass Utheim; Øyvind Palm; Behzod Tashbayev; Tor Paaske Utheim; Hilde Kanli Galtung
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

7.  Risk of Parkinson disease in Sjögren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study.

Authors:  Uei-Han Ju; Feng-Cheng Liu; Chin-Sheng Lin; Wen-Yen Huang; Te-Yu Lin; Chih-Hao Shen; Yu-Ching Chou; Cheng-Li Lin; Kuen-Tze Lin; Chia-Hung Kao; Chao-Hsien Chen; Tse-Yen Yang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 8.  Recent advances of exosomes in immune-mediated eye diseases.

Authors:  Na Li; Lu Zhao; Yankai Wei; Vicki L Ea; Hong Nian; Ruihua Wei
Journal:  Stem Cell Res Ther       Date:  2019-08-30       Impact factor: 6.832

Review 9.  Review: The Lacrimal Gland and Its Role in Dry Eye.

Authors:  Christopher D Conrady; Zachary P Joos; Bhupendra C K Patel
Journal:  J Ophthalmol       Date:  2016-03-02       Impact factor: 1.909

10.  Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome.

Authors:  Behzod Tashbayev; Shermin Rusthen; Alix Young; Bente Brokstad Herlofson; Lene Hystad Hove; Preet Bano Singh; Morten Rykke; Lara Adnan Aqrawi; Xiangjun Chen; Øygunn Aass Utheim; Tor Paaske Utheim; Øyvind Palm; Janicke Liaaen Jensen
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.